BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6430902)

  • 1. The action of virginiamycin M on the acceptor, donor, and catalytic sites of peptidyltransferase.
    Chinali G; Moureau P; Cocito CG
    J Biol Chem; 1984 Aug; 259(15):9563-8. PubMed ID: 6430902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of virginiamycin M on the stability of different ribosomal complexes to ultracentrifugation.
    Chinali G; Vanlinden F; Cocito C
    Biochim Biophys Acta; 1988 May; 950(1):67-74. PubMed ID: 3129013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of erythromycin and virginiamycin S on polypeptide synthesis in cell-free systems.
    Chinali G; Nyssen E; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1988 Nov; 951(1):42-52. PubMed ID: 3142522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribosome protection by tRNA derivatives against inactivation by virginiamycin M: evidence for two types of interaction of tRNA with the donor site of peptidyl transferase.
    Chinali G; Di Giambattista M; Cocito C
    Biochemistry; 1987 Mar; 26(6):1592-7. PubMed ID: 3109469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peptidyltransferase center of Escherichia coli ribosomes: binding sites for the cytidine 3'-phosphate residues of the aminoacyl-tRNA 3'-terminus and the interrelationships between the acceptor and donor sites.
    Bhuta P; Kumar G; Chládek S
    Biochim Biophys Acta; 1982 Feb; 696(2):208-11. PubMed ID: 7037055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the catalytic rate constant of ribosomal peptidyltransferase.
    Synetos D; Coutsogeorgopoulos C
    Biochim Biophys Acta; 1987 Feb; 923(2):275-85. PubMed ID: 3545299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of the 3' terminus of 2'-O-aminoacyl transfer ribonucleic acid by the acceptor site of ribosomal peptidyltransferase.
    Ringer D; Quiggle K; Chládek S
    Biochemistry; 1975 Feb; 14(3):514-20. PubMed ID: 1089429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of the inhibitory activities of type A and type B synergimycins and related antibiotics on ribosomes.
    Di Giambattista M; Chinali G; Cocito C
    J Antimicrob Chemother; 1989 Oct; 24(4):485-507. PubMed ID: 2515187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three tRNA binding sites on Escherichia coli ribosomes.
    Rheinberger HJ; Sternbach H; Nierhaus KH
    Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5310-4. PubMed ID: 7029532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of action of virginiamycin M on the binding of aminoacyl-tRNA to ribosomes directed by elongation factor Tu.
    Chinali G; Moureau P; Cocito CG
    Eur J Biochem; 1981 Sep; 118(3):577-83. PubMed ID: 6117464
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interaction of substrates and substrate-like inhibitors with the peptidyltransferase center from Escherichia coli ribosomes].
    Kukhanova MK; Burd SB; Viktorova LS; Nechipurenko IuD; Gottikh BP
    Mol Biol (Mosk); 1984; 18(3):691-703. PubMed ID: 6206391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrolysis of GTP on elongation factor Tu.ribosome complexes promoted by 2'(3')-O-L-phenylalanyladenosine.
    Campuzano S; Modolell J
    Proc Natl Acad Sci U S A; 1980 Feb; 77(2):905-9. PubMed ID: 6987671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of elongation factor G with N-acetylphenylalanyl transfer RNA-ribosome complexes.
    Modolell J; Cabrer B; Váquez D
    Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3561-5. PubMed ID: 4519646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Puromycin interacts with the donor (P) site of Escherichia coli ribosomes].
    Ivanov IuV; Saminskiĭ EM
    Mol Biol (Mosk); 1984; 18(5):1301-5. PubMed ID: 6390175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of translocation. Binding equilibria between the ribosome, mRNA analogues, and cognate tRNAs.
    Holschuh K; Gassen HG
    J Biol Chem; 1982 Feb; 257(4):1987-92. PubMed ID: 7035457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of the P-site-bound donor in ribosomal peptide-bond formation.
    Synetos D; Coutsogeorgopoulos C
    Eur J Biochem; 1989 Sep; 184(1):47-52. PubMed ID: 2673786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkaloid homoharringtonine inhibits polypeptide chain elongation on human ribosomes on the step of peptide bond formation.
    Tujebajeva RM; Graifer DM; Karpova GG; Ajtkhozhina NA
    FEBS Lett; 1989 Nov; 257(2):254-6. PubMed ID: 2583270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu.
    Wolf H; Chinali G; Parmeggiani A
    Proc Natl Acad Sci U S A; 1974 Dec; 71(12):4910-4. PubMed ID: 4373734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribosome-catalyzed peptide-bond formation with an A-site substrate covalently linked to 23S ribosomal RNA.
    Green R; Switzer C; Noller HF
    Science; 1998 Apr; 280(5361):286-9. PubMed ID: 9535658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribosomal protein L1 from Escherichia coli. Its role in the binding of tRNA to the ribosome and in elongation factor g-dependent gtp hydrolysis.
    Sander G
    J Biol Chem; 1983 Aug; 258(16):10098-103. PubMed ID: 6350280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.